ArticleBlood advances2022

Pharmacodynamics and molecular correlates of response to glofitamab in relapsed/refractory non-Hodgkin lymphoma.

Ann-Marie E Bröske et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.